← Browse by Condition
Medical Condition

atherosclerotic cardiovascular disease in patients with eskd

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT05485961 Phase 2, Phase 3
Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

Enrollment
2,310 pts
Location
United States, Argen...
Sponsor
CSL Behring
View Trial →